Breast/ovarian cancer
81 – 90 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
Bååth, Maria LU ; Jönsson, Jenny-Maria LU ; Westbom Fremer, Sofia LU
; Martin de la Fuente, Laura
LU
; Tran, Lena
LU
; Malander, Susanne
LU
; Kannisto, Päivi
LU
; Måsbäck, Anna
LU
; Honeth, Gabriella
LU
and Hedenfalk, Ingrid
LU
(2021)
In Genes
12(5).
- Contribution to journal › Article
-
Mark
Cancer stem cells and homologous recombination deficiency in serous ovarian and endometrial carcinoma
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study
- Contribution to journal › Article
-
Mark
A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated with Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor) : A Report of 22 Cases
Bennett, Jennifer A. ; Young, Robert H. ; Howitt, Brooke E. ; Croce, Sabrina ; Wanjari, Pankhuri ; Zhen, Chaojie ; Da Cruz Paula, Arnaud ; Meserve, Emily ; Schoolmeester, J. Kenneth and Westbom-Fremer, Sofia LU
, et al.
(2021)
In American Journal of Surgical Pathology
45(8).
p.1061-1074
- Contribution to journal › Article
-
Mark
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study
- Contribution to journal › Article
-
Mark
Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
Stenström, Jenny ; Hedenfalk, Ingrid LU
and Hagerling, Catharina
LU
(2021)
In Breast Cancer Research
23(1).
- Contribution to journal › Article
-
Mark
Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers
Haugen, Mads H. ; Lingjærde, Ole Christian ; Hedenfalk, Ingrid LU
; Garred, Øystein
; Borgen, Elin
; Loman, Niklas
LU
; Hatschek, Thomas
; Børresen-Dale, Anne Lise
; Naume, Bjørn
and Mills, Gordon B.
, et al.
(2021)
In JCO Precision Oncology
5.
p.286-306
- Contribution to journal › Article
-
Mark
Breast cancer risk genes - Association analysis in more than 113,000 women
Dorling, Leila ; Valcich, Jeanette LU ; Li, Minerva LU ; Törngren, Therese LU ; Borg, Åke LU ; Kvist, Anders LU
and Easton, Douglas F.
(2021)
In New England Journal of Medicine
384(5).
p.428-439
- Contribution to journal › Article
-
Mark
Common Susceptibility Loci for Male Breast Cancer
Maguire, Sarah ; Olsson, Håkan LU
; Hedenfalk, Ingrid
LU
and Orr, Nick
(2021)
In Journal of the National Cancer Institute
113(4).
p.453-461
- Contribution to journal › Article
- 2020
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura LU ; Westbom-Fremer, Sofia LU
; Arildsen, Nicolai Skovbjerg
LU
; Hartman, Linda
LU
; Malander, Susanne
LU
; Kannisto, Päivi
LU
; Måsbäck, Anna
LU
and Hedenfalk, Ingrid
LU
(2020)
In Virchows Archiv: an international journal of pathology
477(1).
p.83-91
- Contribution to journal › Article